CDSCO expert panel seeks more data on Covid-19 vaccines from Serum Institute, Bharat Biotech
An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for Covid-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.
You Might Like
💡 newsR Knowledge: Other News Mentions
Watch: India sends doses of SII’s Covishield vaccine to Bahrain, Sri Lanka
Credit: HT Digital Content Duration: 01:29Published
India's gift of 5 lakh doses of Covid-19 vaccines reach Sri LankaSri Lanka's president on Thursday welcomed the first 500,000 doses of a Covid-19 vaccine from India, which has donated the shots to eight countries in the..
SII's vaccines reach Mumbai airport for shipping to Bahrain, Colombo
Credit: ANI Duration: 01:41Published
Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccineAn expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against..
PM visits Covid vaccine centre in Glasgow
Credit: ODN Duration: 01:09Published
COVID pushes Portugal's hospitals to the brink
Credit: Reuters Studio Duration: 01:46Published
Man arrested after suspicious package sent to COVID vaccine plantA man has been arrested after a suspicious package was sent to a coronavirus vaccine production facility in Wales.
PM visits Covid test laboratory in Glasgow
Credit: ODN Duration: 01:21Published
Over 25 lakh COVID vaccine doses administered by 2pm till Jan 28: Health Ministry
Credit: ANI Duration: 01:28Published
Related videos from verified sources
Related news from verified sources